 |
|
Biomarkers in blood could aid diagnosis of crippling, often fatal forms of malaria
December 08, 2008Canadian researchers to describe double malaria breakthrough in New Orleans
Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.
The findings may let doctors detect earlier two crippling malaria variations - one that develops in the placenta of pregnant women affecting countless unborn children, the other, cerebral malaria, that develops in the brain's blood vessels - malaria's most deadly form.
The double breakthrough will be described at annual meetings of the American Society of Tropical Medicine and Hygiene in New Orleans, Louisiana, USA, Dec. 7-11, 2008.
Over-activation of body's natural defences implicated in placental malaria
Tropical disease specialists affiliated with Toronto's McLaughlin-Rotman Centre for Global Health (MRC) say malaria has notoriously stalked pregnant women through the ages.
Many women growing up in areas such as sub-Saharan Africa gradually develop partial immunity to malaria and become relatively impervious to it until their first pregnancy. Often, the expectant mother with placental malaria appears relatively well and the disease is detected only after the child is delivered.
Some 10,000 women die annually from placental malaria, while up to 400,000 develop severe anemia. The disease also causes up to 200,000 infant deaths and countless cases of babies born with low birth weight - a major risk factor for early childhood death.
A decade ago, researchers showed malaria parasites can accumulate in the newly created placenta. But how parasites hiding in the placenta actually result in placental and fetal injury was unclear, says lead researcher and Dr. Kevin Kain, Director of the Sandra A. Rotman Laboratories at the MRC.
Dr. Kain, in collaboration with W. Conrad Liles and colleagues Andrea Conroy, Lena Serghides, Constance Finney, Simon O. Owino, Sanjeev Kumar, D. Channe Gowda, and Julie M. Moore say their work unravels part of this mystery.
They found that women with placental malaria carry a biomarker in their blood -- a protein called C5a, which is an important part of the body's innate defence against infections but one that needs to be carefully controlled.
When overactived by malaria infection, C5a appears to contribute to an excessive inflammatory response and dysrupts normal blood vessel growth in the placenta, raising the risk of spontaneous abortions or low birth weight infants.
Tests on pregnant women in Kenya revealed that those with placental malaria had elevated levels of C5a in their blood compared to expectant mothers without the disease. The discovery may help identify placental malaria carriers early enough to potentially prevent tragic consequences through better targeted treatment strategies.
"Children born with low birth weight from placental malaria have several strikes against them before they've drawn a breath," says Dr. Kain, who is also Director of the Center for Travel and Tropical Medicine at Toronto General Hospital. "Any additional illness that comes along in early childhood is more likely to kill them."
"A test that helps detect placental malaria means women can be treated earlier pregnancy, reducing the risk of death or anemia for them, and perhaps saving their babies from malformation or miscarriage."
Protein "biomarker" linked to cerebral malaria, predicts survival
Meanwhile, Drs. Kain and Liles, with colleagues Fiona E. Lovegrove, Erin I. Lafferty, Nimerta Rajwans, and Michael Hawkes, together with collaborators from Thailand, Noppadon Tangpukdee Srivicha Krudsood, Sornchai Looareesuwan, and Uganda, Robert O. Opoka and Chandy C. John, will report in New Orleans on a similar breakthrough: biomarkers that reveal potential victims of cerebral malaria, the disease's most fatal form.
Cerebral malaria is a scourge of people with little developed immunity, affecting particularly African children under five years old and other non-immune adults and travellers to developing countries. It kills 10 to 40% of its victims.
Some 2 to 5% of children with malaria develop the cerebral form. Millions of invading parasites damage the blood vessels of the brain resulting in coma and frequently death. Surprisingly, those who survive it emerge relatively intact neurologically.
Blood tests on patients with cerebral malaria were compared with samples from patients with uncomplicated malaria and from healthy test control subjects.
Cerebral malaria patients were found to have abnormal levels of proteins that regulate the activation of blood vessels known as angiopoietins. Angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2) must be in careful balance to maintain healthly endothelial cells that line blood vessels.
In cerebral malaria, the research showed ANG-1 and ANG-2 were dysregulated, likely contributing to excessive activation of the endothelial cells and parasite obstruction of brain blood vessels, associated with cerebral malaria.
High levels of ANG-2 and low levels of ANG-1 were associated with the severity of disease; the levels recorded on admission to hospital predicted which children would subsequently die.
The accuracy of ANG-1 and ANG-2 levels in identifying cerebral malaria was very high (80 to 100%; in African children and Thai adults respectively)
The finding could help doctors spot at-risk individuals early in the course of the disease, with profound implications for triaging critically ill children in developing countries and effectively allocating scarce health care resources. Furthermore, drugs or agents that block ANG-2 or enhance ANG-1 may have a therapeutic role in preventing or treating cerebral malaria.
Says Dr. Liles: "While there is still much work ahead related to this finding, we believe it could soon help improve priority setting by doctors as they decide which patients need the most intensive anti-malaria therapy and supportive care once symptoms are detected."
Program on Life Sciences, Ethics and Policy,McLaughlin-Rotman Centre for Global Health
The double breakthrough will be described at annual meetings of the American Society of Tropical Medicine and Hygiene in New Orleans, Louisiana, USA, Dec. 7-11, 2008.
Over-activation of body's natural defences implicated in placental malaria
Tropical disease specialists affiliated with Toronto's McLaughlin-Rotman Centre for Global Health (MRC) say malaria has notoriously stalked pregnant women through the ages.
Many women growing up in areas such as sub-Saharan Africa gradually develop partial immunity to malaria and become relatively impervious to it until their first pregnancy. Often, the expectant mother with placental malaria appears relatively well and the disease is detected only after the child is delivered.
Some 10,000 women die annually from placental malaria, while up to 400,000 develop severe anemia. The disease also causes up to 200,000 infant deaths and countless cases of babies born with low birth weight - a major risk factor for early childhood death.
A decade ago, researchers showed malaria parasites can accumulate in the newly created placenta. But how parasites hiding in the placenta actually result in placental and fetal injury was unclear, says lead researcher and Dr. Kevin Kain, Director of the Sandra A. Rotman Laboratories at the MRC.
Dr. Kain, in collaboration with W. Conrad Liles and colleagues Andrea Conroy, Lena Serghides, Constance Finney, Simon O. Owino, Sanjeev Kumar, D. Channe Gowda, and Julie M. Moore say their work unravels part of this mystery.
They found that women with placental malaria carry a biomarker in their blood -- a protein called C5a, which is an important part of the body's innate defence against infections but one that needs to be carefully controlled.
When overactived by malaria infection, C5a appears to contribute to an excessive inflammatory response and dysrupts normal blood vessel growth in the placenta, raising the risk of spontaneous abortions or low birth weight infants.
Tests on pregnant women in Kenya revealed that those with placental malaria had elevated levels of C5a in their blood compared to expectant mothers without the disease. The discovery may help identify placental malaria carriers early enough to potentially prevent tragic consequences through better targeted treatment strategies.
"Children born with low birth weight from placental malaria have several strikes against them before they've drawn a breath," says Dr. Kain, who is also Director of the Center for Travel and Tropical Medicine at Toronto General Hospital. "Any additional illness that comes along in early childhood is more likely to kill them."
"A test that helps detect placental malaria means women can be treated earlier pregnancy, reducing the risk of death or anemia for them, and perhaps saving their babies from malformation or miscarriage."
Protein "biomarker" linked to cerebral malaria, predicts survival
Meanwhile, Drs. Kain and Liles, with colleagues Fiona E. Lovegrove, Erin I. Lafferty, Nimerta Rajwans, and Michael Hawkes, together with collaborators from Thailand, Noppadon Tangpukdee Srivicha Krudsood, Sornchai Looareesuwan, and Uganda, Robert O. Opoka and Chandy C. John, will report in New Orleans on a similar breakthrough: biomarkers that reveal potential victims of cerebral malaria, the disease's most fatal form.
Cerebral malaria is a scourge of people with little developed immunity, affecting particularly African children under five years old and other non-immune adults and travellers to developing countries. It kills 10 to 40% of its victims.
Some 2 to 5% of children with malaria develop the cerebral form. Millions of invading parasites damage the blood vessels of the brain resulting in coma and frequently death. Surprisingly, those who survive it emerge relatively intact neurologically.
Blood tests on patients with cerebral malaria were compared with samples from patients with uncomplicated malaria and from healthy test control subjects.
Cerebral malaria patients were found to have abnormal levels of proteins that regulate the activation of blood vessels known as angiopoietins. Angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2) must be in careful balance to maintain healthly endothelial cells that line blood vessels.
In cerebral malaria, the research showed ANG-1 and ANG-2 were dysregulated, likely contributing to excessive activation of the endothelial cells and parasite obstruction of brain blood vessels, associated with cerebral malaria.
High levels of ANG-2 and low levels of ANG-1 were associated with the severity of disease; the levels recorded on admission to hospital predicted which children would subsequently die.
The accuracy of ANG-1 and ANG-2 levels in identifying cerebral malaria was very high (80 to 100%; in African children and Thai adults respectively)
The finding could help doctors spot at-risk individuals early in the course of the disease, with profound implications for triaging critically ill children in developing countries and effectively allocating scarce health care resources. Furthermore, drugs or agents that block ANG-2 or enhance ANG-1 may have a therapeutic role in preventing or treating cerebral malaria.
Says Dr. Liles: "While there is still much work ahead related to this finding, we believe it could soon help improve priority setting by doctors as they decide which patients need the most intensive anti-malaria therapy and supportive care once symptoms are detected."
Program on Life Sciences, Ethics and Policy,McLaughlin-Rotman Centre for Global Health
Malaria Current Events and Malaria News RSSPATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.
Global challenges and opportunities in fighting HIV/AIDS and neglected diseases
Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs.
Media availability: The role of biomedical research in malaria eradication
Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year.
Ineffective monotherapies common in high-burden malarious countries
ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk.
New tool promises more accurate antimalarial drug dosing
Scientists at LSTM have developed a tool to support the development of appropriate age-based dosing regimens for malaria drugs.
Cell phones become handheld tools for global development
Mobile phones are on the verge of becoming powerful tools to collect data on many issues, ranging from global health to the environment.
Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.
UM School of Medicine researchers find extreme genetic variability in malaria parasite
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world.
Outfoxing pox: Developing a new class of vaccine candidates
In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.
Ironing out the genetic cause of hemoglobin problems
A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.
More Malaria Current Events and Malaria News Articles
 |
The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard (Author) Malaria sickens hundreds of millions of people -- and kills one to three million -- each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe? From Russia to Bengal to Palm Beach, Randall Packard's far-ranging narrative traces the natural and social forces that help malaria spread and make it deadly. He finds that war, land development, crumbling health systems, and globalization -- coupled with climate change and changes in the distribution and flow of water -- create conditions in which malaria's carrier mosquitoes thrive. The combination of... |
 |
The Malaria Capers : More Tales of Parasites and People, Research and Reality by Robert S. Desowitz (Author) "Reads like a murder mystery. . . . [Desowitz] writes with uncommon lucidity and verse, leaving the reader with a vivid understanding of malaria and other tropical diseases, and the ways in which culture, climate and politics have affected their spread and containment."—New York Times Why, Robert S. Desowitz asks, has biotechnical research on malaria produced so little when it had promised so much? An expert in tropical diseases, Desowtiz searches for answers in this provocative book. . |
![GIANTmicrobes: Malaria (Plasmodium Falciparum) [Toy]](http://ecx.images-amazon.com/images/I/219e7hJvowL._SL160_.jpg) |
GIANTmicrobes: Malaria (Plasmodium Falciparum) [Toy] by Giant Microbes GIANTmicrobes are fun and educationala great way to learn about various health topics and the microscopic critters that are found in and around us. Each microbe character is 5-7 in size--over a million times their actual size! Perfect for teachers, parents and budding scientiststhey also make humorous gifts. Each microbe comes with an information tag including scientific name, an image of the actual microbe, and a mini history and science lesson. Not suitable for children under 3 years. Our products are made by top manufacturers who care about toy safety, quality and value. Your order will ship factory fresh directly from our warehouse to your door. We carefully inspect and beautifully package every order before shipment to ensure that you receive high quality products that are... |
 |
Humanity's Burden: A Global History of Malaria (Studies in Environment and History) by James L.A. Webb Jr. (Author) Humanity's Burden provides a panoramic overview of the history of malaria. It traces the long arc of malaria out of tropical Africa into Eurasia, its transfer to the Americas during the early years of the Columbian exchange, and its retraction from the middle latitudes into the tropics since the late nineteenth century. Adopting a broadly comparative approach to historical patterns and processes, it synthesizes research findings from the natural and social sciences and weaves these understandings into a narrative that reaches from the earliest evidence of malaria infections in tropical Africa up to the present. Written in a style that is easily accessible to non-specialists, it considers the significance of genetic mutations, diet, lifestyle, migration, warfare, palliative and curative... |
 |
Compiled 1981-1984 by Malaria! |
 |
First Comes Love, Then Comes Malaria: How a Peace Corps Poster Boy Won My Heart and a Third World Adventure Changed My Life by Eve Brown-Waite (Author) In this laugh-out-loud funny memoir, a pampered city girl falls head over little black heels in love with a Peace Corps poster boy and follows him —literally–to the ends of the earth. Eve Brown always thought she would join the Peace Corps someday, although she secretly worried about life without sushi, frothy coffee drinks and air conditioning. But with college diploma in hand, it was time to put up or shut up. So with some ambivalence she arrives at the Peace Corps office–sporting her best safari chic attire –to casually look into the steps one might take if one were to become a global humanitarian, a la Angelina Jolie. But when Eve meets John, her dashing young Peace Corps recruiter, all her ambivalence flies out the window. She absolutely must join the Peace Corps -... |
 |
Malaria: Fever Wars Starring: Artist Not Provided |
 |
Parasites! - The Malaria Parasite by Sheila Wyborny (Author) Malaria is a serious disease caused by a tiny mosquito-borne parasite called Plasmodium. It once affected entire empires, but thanks to the work of health organizations, malaria is now mostly confined to warm, moist climates. Scientists are still at work today, however, developing methods of curing the disease and destroying its carriers. |
 |
Compiled 1981-84 Malaria! (Primary Contributor) |
 |
Molecular Approaches to Malaria by Irwin W. Sherman (Editor) "Molecular Approaches to Malaria" provides an overview of the rapid and significant developments that have occurred in malaria research, including the 2002 genome sequencing of Plasmodium falciparum and its mosquito vector, Anopheles gambiae. This work: provides a concise source of up-to-date research findings; appeals to a diverse audience, including malaria researchers, teachers, investigators, and public health professionals; offers contributions by recognized malaria researchers with practical experience; and, presents comprehensive coverage of topics including a clearly written introduction to Plasmodium molecular biology. |
| © 2009 BrightSurf.com |